Table 2.
Clinical and hematological parameters of patients with or without MRI abnormalities.
| MRI Abnormalities | ||||
|---|---|---|---|---|
| Yes (n = 11) | No (n = 8) | Yes (n = 11) | No (n = 8) | |
| Data at diagnosis | Data at last follow-up | |||
| Age (yrs) | 50 ± 17* | 32 ± 10 | 60 ± 17* | 43 ± 8 |
| Hb (g/dL) | 9.5 ± 1.5 | 9.9 ± 1.6 | 12.2 ± 1.5* | 10.4 ± 1.4 |
| LDH (t > ULN) | 5.8 ± 4.4 | 4.1 ± 2.9 | 2.1 ± 1.8 | 2.9 ± 2.2 |
| Reticulocyte counts (x103/mmc) | 105 ± 60 | 130 ± 69 | 134 ± 66 | 148 ± 60 |
| GPI neg PMN cells (%) | 65 ± 23 | 60 ± 27 | 63 ± 34 | 84 ± 11 |
| WBC (μL) | 3928 ± 1260 | 4490 ± 1709 | 3702 ± 1060 | 3676 ± 583 |
| PMN cells (μL) | 2045 ± 961 | 2239 ± 885 | 1931 ± 655 | 2096 ± 471 |
| Plt (μL) | 178091 ± 86290 | 131875 ± 101035 | 165564 ± 82344 | 162000 ± 65937 |
Values are expressed as mean ± SD; *denotes p < 0.05, MRI abnormalities versus no MRI abnormalities.